LDX has come out from death bed with vengeance, and yes I completely agree with size of US population and lack of Medicare system like in Australia, FebriDx approval by FDA is not only lifesaver but it may turn out to be a game changer as self diagnostic test who doesn't have private medical cover.
I don't expect SP to go to IPO price of $0.50 anytime soon (anything possible) but expect $0.20 is quite achievable within 3-5 months with distribution channel shorted in US. Europe is already covered under last announcement with Henry Schein.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-14
Add to My Watchlist
What is My Watchlist?
